The growth of Viagra and its influence on the pharmaceutical landscape presents a complex question for shareholders. While the early sales data were astounding, the exclusivity has lapsed, leading to a wave of copycat https://joycewxnz114993.blogdeazar.com/41753137/the-blue-pill-and-the-pharmaceutical-industry-a-dangerous-opportunity